| Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors DZJ Chu, NP Lang, C Thompson, PK Osteen, KC Westbrook Cancer 63 (2), 364-367, 1989 | 785 | 1989 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 672 | 2021 |
| Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study GS Nowakowski, B LaPlant, WR Macon, CB Reeder, JM Foran, ... J Clin Oncol 33 (3), 251-257, 2015 | 416 | 2015 |
| Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy MJ Maurer, H Ghesquières, JP Jais, TE Witzig, C Haioun, CA Thompson, ... Journal of Clinical Oncology 32 (10), 1066-1073, 2014 | 401 | 2014 |
| Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Specialized Program of Research … BK Link, MJ Maurer, GS Nowakowski, SM Ansell, WR Macon, SI Syrbu, ... Journal of clinical oncology 31 (26), 3272, 2013 | 337 | 2013 |
| Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma LF Porrata, K Ristow, JP Colgan, TM Habermann, TE Witzig, DJ Inwards, ... Haematologica 97 (2), 262, 2012 | 240 | 2012 |
| Early event status informs subsequent outcome in newly diagnosed follicular lymphoma MJ Maurer, E Bachy, H Ghesquières, SM Ansell, GS Nowakowski, ... American journal of hematology 91 (11), 1096-1101, 2016 | 222 | 2016 |
| Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors CA Thompson, ME Charlson, E Schenkein, MT Wells, RR Furman, ... Annals of oncology 21 (11), 2262-2266, 2010 | 201 | 2010 |
| Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts C Sarkozy, MJ Maurer, BK Link, H Ghesquieres, E Nicolas, CA Thompson, ... Journal of clinical oncology 37 (2), 144, 2019 | 199 | 2019 |
| Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines SM Ansell, RA Kyle, CB Reeder, R Fonseca, JR Mikhael, WG Morice, ... Mayo Clinic Proceedings 85 (9), 824-833, 2010 | 199 | 2010 |
| Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma JR Cerhan, SI Berndt, J Vijai, H Ghesquières, J McKay, SS Wang, Z Wang, ... Nature genetics 46 (11), 1233-1238, 2014 | 187 | 2014 |
| Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types JN Sampson, WA Wheeler, M Yeager, O Panagiotou, Z Wang, SI Berndt, ... Journal of the National Cancer Institute 107 (12), djv279, 2015 | 181 | 2015 |
| Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma CA Thompson, H Ghesquieres, MJ Maurer, JR Cerhan, P Biron, ... Journal of clinical oncology 32 (31), 3506, 2014 | 175 | 2014 |
| Bowel perforation in intestinal lymphoma: incidence and clinical features R Vaidya, TM Habermann, JH Donohue, KM Ristow, MJ Maurer, ... Annals of oncology 24 (9), 2439-2443, 2013 | 152 | 2013 |
| Pure red cell aplasia associated with thymoma: clinical insights from a 50‐year single‐institution experience CA Thompson, DP Steensma British journal of haematology 135 (3), 405-407, 2006 | 148 | 2006 |
| Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016 P Kapoor, SM Ansell, R Fonseca, A Chanan-Khan, RA Kyle, SK Kumar, ... JAMA oncology 3 (9), 1257-1265, 2017 | 138 | 2017 |
| Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study CC Lees, A Lojacono, C Thompson, L Danti, RS Black, P Tanzi, IR White, ... Obstetrics & Gynecology 94 (3), 403-408, 1999 | 136 | 1999 |
| Andropause: symptom management for prostate cancer patients treated with hormonal ablation CA Thompson, TD Shanafelt, CL Loprinzi The oncologist 8 (5), 474-487, 2003 | 134 | 2003 |
| Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region CF Skibola, SI Berndt, J Vijai, L Conde, Z Wang, M Yeager, ... The American Journal of Human Genetics 95 (4), 462-471, 2014 | 127 | 2014 |
| Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma TC El-Galaly, CY Cheah, MD Bendtsen, GS Nowakowski, R Kansara, ... European Journal of Cancer 93, 57-68, 2018 | 117 | 2018 |
